Data Protection and Cybersecurity
Topic 1: 2026 cyber trends: what to watch for and what you can do The cyber threat landscape in 2025 was varied, with greater ebbs and flows in threat actor activity than in previous years.
28 April 2026
Debevoise & Plimpton LLP houses a team known for its strength in acquisitions and class actions across the pharma and healthcare spaces. Andrew Bab is noted for his vast experience in private equity-focused healthcare and life sciences work, and M&A. Mark Goodman is a key contact for all matters relating to commercial litigation and white-collar crime within the healthcare space, areas in which Maura Monaghan is also an expert. Kevin Rinker has deep knowledge of private equity buyouts, as does Jennifer Chu, and Washington DC-based Paul Rubin is a key figure within the team, known for his experience in FDA and FTC compliance work, and the regulatory aspects of M&A.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Sector knowledge
Client satisfaction: NPS ®
Testimonials
Collated independently by Legal 500 research team.
- ‘Very professional, capable and experienced in Healthcare M&A.’
- ‘High level of expertise with wide range of complementary skills.’
- ‘Extraordinary team who work incredibly well together and maximize their different skills and areas of expertise.’
Key clients
- agilon
- Former CEO of Sandoz
- Carlyle
- Former directors and shareholders of Purdue Pharma, Inc.
- Clayton, Dubilier & Rice, LLC
- Deutsche Bank
- EmblemHealth
- Group Health Incorporated, Inc.
- Gedeon Richter
- Gentiva
- GlaxoSmithKline
- Hospital Corporation of America and subsidiaries
Work highlights
Advised Clayton, Dubilier & Rice on its acquisition, together with TowerBrook Capital Partners, of R1 RCM Inc. at an enterprise value of $8.9bn.
Representing certain former directors and shareholders of Purdue Pharma, Inc., in defending litigation regarding prescription opioids in numerous for a across the country, including a federal multi-district litigation, actions brought by states attorneys general and a high-profile case before the US Supreme Court, and in efforts to negotiate a global settlement in bankruptcy court.
Obtained a highly favorable settlement for EmblemHealth and its subsidiary Group Health Incorporated in a long-running putative class action lawsuit.
Practice head
Andrew Bab; Jennifer Chu; Mark Goodman; Maura Monaghan; Kevin Rinker; Paul Rubin